Relay Therapeutics, Inc. RLAY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$272.71M+1.4% | -$276.48M+7.1% | -$297.59M+4.5% | -$311.55M+6.6% | -$333.39M+1.3% | ||
| $2.85M-19.8% | $3.56M-17.1% | $4.29M-12.6% | $4.91M-6.9% | $5.28M-3.4% | ||
| $53.63M-14.1% | $62.42M-6.8% | $66.99M-9.4% | $73.94M-14.3% | $86.28M-8.4% | ||
| -$213.36M+9.4% | -$235.46M+5.2% | -$248.46M+5.0% | -$261.42M+3.9% | -$271.99M-9.2% | ||
| —— | $411K+0.2% | $410K-35.6% | $637K+2.4% | $622K-69.2% | ||
| $183.24M-5.0% | $192.8M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$59.91M-199% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.